Impact of the Intestinal Microbiome on HIV/SIV Vaccines

肠道微生物组对 HIV/SIV 疫苗的影响

• 批准号: 10077897
• 负责人: Megan T Baldridge
• 金额: $ 72.64万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-04-15 至 2022-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10077897
• 关键词: Acquired Immunodeficiency Syndrome; Address; Adenoviruses; Animal Model; Antigens; Autophagocytosis; Bacteria; Bacteroides fragilis; Biological; Cells; Cessation of life; Clinical Research; Collaborations; Cross-Sectional Studies; Data; Enteral; Family; Generations; Genes; Grant; HIV; HIV Infections; HIV vaccine; HIV/SIV vaccine; Human; Human Genetics; Immune; Immune response; Immune system; Immunologic Deficiency Syndromes; Infection; Inflammatory; International; Intestines; Link; Macaca mulatta; Metadata; Methods; Molecular; Monkeys; Mucous Membrane; Mus; Nature; Observational Study; Pathogenicity; Patients; Pattern; Phase; Polysaccharides; Primates; Publishing; Regulatory T-Lymphocyte; Role; SIV; Sampling; Technology; Testing; Time; Uganda; Vaccination; Vaccines; Variant; Virus; antiviral immunity; bacteriome; base; clinically significant; cohesion; cohort; dysbiosis; efficacy trial; enteric pathogen; gastrointestinal epithelium; gut microbiome; human disease; immune activation; immunogenicity; microbiome; microbiome components; microbiome research; pathogen; pathogenic bacteria; pathogenic virus; programs; response; systemic inflammatory response; tool; tool development; vaccine candidate; vaccine response; vaccine trial; virome

PROJECT SUMMARY In this revised application (priority score 29 and percentile 15%, which narrowly missed the 13% payline), we seek to define the impact of the microbiome on vaccine responses in a program spanning from observational studies in a human vaccine trial to studies in animal models to define the relevant functions of the microbiome. This revised application is built upon the strong 6 year collaboration between Dr. Dan Barouch and Dr. Skip Virgin. This collaboration included a highly productive multi-PI R01 grant (OD011170) to define the effects of pathogenic SIV and HIV infection on the enteric virome and bacterial microbiome. This collaboration led to several advances relevant to this application. Importantly, the technologies to evaluate the microbiome including the bacterial microbiome and virome and for defining the relationship of components of the microbiome to vaccine immunogenicity metadata were developed and published. The availability of these methods provides us with a unique opportunity to leverage an on going human vaccine trial to probe the important hypothesis that the nature and extent of vaccine responses is regulated by the microbiome. Data from many groups now show that that the microbiome regulates antiviral immunity, functions of key innate immune cells and vaccine-induced humoral and cellular immune responses. Based on evidence that bacterial and other microbiome constituents alter immune responses, the development of tools for analysis of the virome and bacterial microbiome, and the immediate availability of a unique set of human samples from a highly relevant international phase 1/2a clinical study of an HIV vaccine candidate that will likely advance into large- scale efficacy trials (A004/IPCAVD009; NCT02315703), we now propose, to test the hypothesis that variations in the intestinal microbiome influence vaccine immunogenicity in humans, rhesus monkeys, and mice. To address this important hypothesis, we propose the following two Specific Aims: Aim 1: To assess the impact of the intestinal microbiome on vaccine-elicited immune responses in humans. Aim 2: To determine whether experimental alterations of the intestinal microbiome impact vaccine- elicited immune responses in animal models.

项目概要 在此修订后的应用程序中（优先级得分为 29，百分位数为 15%，仅差一点就达到了 13%） 支付线），我们试图在一个项目中定义微生物组对疫苗反应的影响 人类疫苗试验中的观察性研究和动物模型研究，以确定相关功能 微生物组。此修订版应用程序建立在 Dan Barouch 博士长达 6 年的密切合作基础上 和斯基普·维珍博士。此次合作包括一项高效的多 PI R01 资助 (OD011170)，用于定义 致病性 SIV 和 HIV 感染对肠道病毒组和细菌微生物组的影响。这 合作带来了与该应用相关的多项进展。重要的是，评估技术 微生物组，包括细菌微生物组和病毒组，并用于定义各组分之间的关​​系 开发并发布了微生物组与疫苗免疫原性元数据。这些的可用性 方法为我们提供了一个独特的机会，利用正在进行的人体疫苗试验来探索 疫苗反应的性质和程度受微生物组调节的重要假设。数据 许多研究小组现在表明，微生物组调节抗病毒免疫、关键先天性功能 免疫细胞和疫苗诱导的体液和细胞免疫反应。基于细菌的证据 和其他微生物组成分改变免疫反应，病毒组分析工具的开发 和细菌微生物组，以及立即从高度可获取的一组独特的人类样本 HIV 候选疫苗的相关国际 1/2a 期临床研究可能会进入大规模临床研究 我们现在提出，规模功效试验（A004/IPCAVD009；NCT02315703）来检验变异的假设 肠道微生物组中的微生物影响人类、恒河猴和小鼠的疫苗免疫原性。到 针对这一重要假设，我们提出以下两个具体目标： 目标 1：评估肠道微生物组对疫苗引发的免疫反应的影响 人类。 目标 2：确定肠道微生物组的实验改变是否会影响疫苗 在动物模型中引发免疫反应。

项目成果

The induction of neutralizing antibodies by synthetic peptides of the envelope protein of type D simian retrovirus-1 (SRV-1).

D 型猿猴逆转录病毒 (SRV-1) 包膜蛋白的合成肽诱导中和抗体。

• DOI: 10.1016/0161-5890(91)90055-o
• 发表时间: 1991
• 期刊: Molecular immunology
• 影响因子: 3.6
• 作者: Torres,JV;Werner,LL;Malley,A;Benjamini,E
• 通讯作者: Benjamini,E

Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.

• DOI: 10.1016/j.cell.2021.05.040
• 发表时间: 2021-06-24
• 期刊: Cell
• 影响因子: 64.5
• 作者: He X;Chandrashekar A;Zahn R;Wegmann F;Yu J;Mercado NB;McMahan K;Martinot AJ;Piedra-Mora C;Beecy S;Ducat S;Chamanza R;Huber SR;van Heerden M;van der Fits L;Borducchi EN;Lifton M;Liu J;Nampanya F;Patel S;Peter L;Tostanoski LH;Pessaint L;Van Ry A;Finneyfrock B;Velasco J;Teow E;Brown R;Cook A;Andersen H;Lewis MG;Schuitemaker H;Barouch DH
• 通讯作者: Barouch DH

Enteric virome negatively affects seroconversion following oral rotavirus vaccination in a longitudinally sampled cohort of Ghanaian infants.

• DOI: 10.1016/j.chom.2021.12.002
• 发表时间: 2022-01-12
• 期刊: Cell host & microbe
• 影响因子: 30.3
• 作者: Kim AH;Armah G;Dennis F;Wang L;Rodgers R;Droit L;Baldridge MT;Handley SA;Harris VC
• 通讯作者: Harris VC

Rapid Loss of CD4 T Cells by Pyroptosis during Acute SIV Infection in Rhesus Macaques.

• DOI: 10.1128/jvi.00808-22
• 发表时间: 2022-09-14
• 期刊: Journal of virology
• 影响因子: 5.4

Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy.

• DOI: 10.4049/jimmunol.1800885
• 发表时间: 2018-11-01
• 期刊: Journal of immunology (Baltimore, Md. : 1950)
• 作者: Badamchi-Zadeh A;Moynihan KD;Larocca RA;Aid M;Provine NM;Iampietro MJ;Kinnear E;Penaloza-MacMaster P;Abbink P;Blass E;Tregoning JS;Irvine DJ;Barouch DH
• 通讯作者: Barouch DH